Lutetium-177 (¹⁷⁷Lu)

A well-established isotope for peptide receptor radionuclide therapy (PRRT), widely used in treating neuroendocrine tumors and prostate cancer. We provide high-purity Lu-177 to support therapeutic and diagnostic workflows.